45 CFR § 180 compliance
F · 55
This hospital published little of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
12,320
Insurances with rates
11
CPT / HCPCS codes
10,714
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| Q2043 | SIPULEUCEL-T IN LACTATED RINGERS 50 MILLION CELL/250 ML IV SUSPENSION | $140,330 | $140,330 | — | — | 31 |
| J9043 | CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION | $112,310 | $112,310 | — | — | 31 |
| J9228 | IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION | $70,679 | $70,679 | — | — | 31 |
| J2507 | PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION | $58,372 | $58,372 | — | — | 31 |
| J3357 | USTEKINUMAB 90 MG/ML SUBCUTANEOUS SYRINGE | $57,154 | $57,154 | — | — | 31 |
| J2350 | OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION | $39,893 | $39,893 | — | — | 31 |
| J9298 | NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION | $31,716 | $31,716 | — | — | 31 |
| J9307 | PRALATREXATE 40 MG/2 ML (20 MG/ML) INTRAVENOUS SOLUTION | $29,344 | $29,344 | — | — | 31 |
| J0896 | LUSPATERCEPT-AAMT 75 MG SUBCUTANEOUS SOLUTION | $25,001 | $25,001 | — | — | 31 |
| 77372 | HB SRS TX CRANIAL LESION(S) 1 SESSION LINEAR BASED | $23,569 | $23,569 | — | — | 31 |
| J9042 | BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION | $22,465 | $22,465 | — | — | 31 |
| J1930 | LANREOTIDE 120 MG/0.5 ML SUBCUTANEOUS SYRINGE | $22,146 | $22,146 | — | — | 31 |
| J9119 | CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION | $21,820 | $21,820 | — | — | 31 |
| J2997 | ALTEPLASE IV 100 MG (FOR STROKE) | $19,650 | $19,650 | — | — | 31 |
| J9316 | PERTUZUMAB 600 MG-TRASTUZUMAB 600 MG-HYALURONID-ZZXF/10 ML SUBCUT SOLN | $19,619 | $19,619 | — | — | 31 |
| J9228 | IPILIMUMAB 50 MG/10 ML (5 MG/ML) INTRAVENOUS SOLUTION | $19,429 | $19,429 | — | — | 31 |
| J9144 | DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN | $19,376 | $19,376 | — | — | 31 |
| J2323 | NATALIZUMAB 300 MG/15 ML INTRAVENOUS SOLUTION | $19,363 | $19,363 | — | — | 31 |
| J3380 | VEDOLIZUMAB 300 MG INTRAVENOUS SOLUTION | $19,012 | $19,012 | — | — | 31 |
| J9301 | OBINUTUZUMAB 1,000 MG/40 ML INTRAVENOUS SOLUTION | $17,556 | $17,556 | — | — | 31 |
| J9299 | NIVOLUMAB 240 MG/24 ML INTRAVENOUS SOLUTION | $17,044 | $17,044 | — | — | 31 |
| J2506 | PEGFILGRASTIM 6 MG/0.6 ML SUBCUTANEOUS SYRINGE | $16,959 | $16,959 | — | — | 31 |
| J3101 | TENECTEPLASE 50 MG IV SOLUTION (FOR STROKE) | $16,579 | $16,579 | — | — | 31 |
| J9311 | RITUXIMAB 1,400 MG/11.7 ML (120 MG/ML)-HYALURONIDASE SUBCUTANEOUS SOLN | $16,210 | $16,210 | — | — | 31 |
| J1299 | ECULIZUMAB 300 MG/30 ML INTRAVENOUS SOLUTION | $16,078 | $16,078 | — | — | 31 |
| J9308 | RAMUCIRUMAB 10 MG/ML INTRAVENOUS SOLUTION | $15,947 | $15,947 | — | — | 31 |
| J9306 | PERTUZUMAB 420 MG/14 ML (30 MG/ML) INTRAVENOUS SOLUTION | $14,244 | $14,244 | — | — | 31 |
| J9271 | PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION | $12,655 | $12,655 | — | — | 31 |
| J1162 | DIGOXIN IMMUNE FAB 40 MG INTRAVENOUS SOLUTION | $12,434 | $12,434 | — | — | 31 |
| J9342 | THIOTEPA 100 MG SOLUTION FOR INJECTION | $11,585 | $11,585 | — | — | 31 |
| J9356 | TRASTUZUMAB 600 MG-HYALURONIDASE-OYSK 10,000 UNIT/5 ML SUBCUT SOLUTION | $11,524 | $11,524 | — | — | 31 |
| J9173 | DURVALUMAB 50 MG/ML INTRAVENOUS SOLUTION | $10,580 | $10,580 | — | — | 62 |
| Q5111 | PEGFILGRASTIM-CBQV 6 MG/0.6 ML SUBCUTANEOUS SYRINGE | $10,291 | $10,291 | — | — | 31 |
| J0896 | LUSPATERCEPT-AAMT 25 MG SUBCUTANEOUS SOLUTION | $10,083 | $10,083 | — | — | 31 |
| 0721 | HB LABOR IV | $9,884 | $9,884 | — | — | 30 |
| J2353 | OCTREOTIDE,MICROSPHERES ER 10 MG INTRAMUSCULAR SUSP, EXTENDED RELEASE | $9,793 | $9,793 | — | — | 31 |
| J9354 | ADO-TRASTUZUMAB EMTANSINE 100 MG INTRAVENOUS SOLUTION | $9,652 | $9,652 | — | — | 31 |
| J0630 | CALCITONIN (SALMON) 200 UNIT/ML INJECTION SOLUTION | $9,423 | $9,423 | — | — | 31 |
| 33210 | HB INSERT/REPLACE TEMP SINGLE C. PM | $9,260 | $9,260 | — | — | 31 |
| 63685 | HB INSERT/RPLCMT SPINAL NPG/RCVR POCKET CRTJ&CONNJ | $9,252 | $9,252 | — | — | 31 |
| J9355 | TRASTUZUMAB 150 MG INTRAVENOUS SOLUTION | $8,733 | $8,733 | — | — | 31 |
| 77301 | HB IMRT PLANNING | $8,554 | $8,554 | — | — | 31 |
| 93602 | HB INTRA ARTERIAL RECORDING | $8,048 | $8,048 | — | — | 31 |
| 78816 | HB RADIANT PET/CT TUMOR IMAGE FULL BODY | $7,825 | $7,825 | — | — | 31 |
| 78815 | HB RADIANT PET/CT TUMOR IMAGE SKUL-THIGH | $7,654 | $7,654 | — | — | 31 |
| J9047 | CARFILZOMIB 60 MG INTRAVENOUS SOLUTION | $7,653 | $7,653 | — | — | 31 |
| J7168 | HUM PROTHROMBIN CPLX 4 FACTOR 1000 UNITS (VOLUME) | $7,612 | $7,612 | — | — | 31 |
| J9217 | LEUPROLIDE ACETATE 45 MG (6 MONTH) SUBCUTANEOUS SYRINGE | $7,594 | $7,594 | — | — | 31 |
| J9145 | DARATUMUMAB 20 MG/ML INTRAVENOUS SOLUTION | $7,498 | $7,498 | — | — | 62 |
| J1561 | IMMUNE GLOB G 20 GRAM/200 ML(10%)-GLY-IGA AVE 46 MCG/ML INJECTION SOLN | $7,476 | $7,476 | — | — | 31 |
Showing top 50 of 12,320 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.